Synonyms: HuZAF
Compound class:
Antibody
|
Immunopharmacology Comments |
Fontolizumab achieves its immunosuppressive activity via neutralisation of circulating IFNγ [4]. |
Immunopharmacology Disease | |||
Disease | X-Refs | Comment | References |
Crohn's disease |
Disease Ontology:
DOID:8778 OMIM: 266600 Orphanet: ORPHA206 |
Fontolizumab has completed Phase 2 clinical trial in patients with moderate to severe Crohn's disease- see NCT00072943 | 2-3 |